The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1069 (1) , 120-126
- https://doi.org/10.1016/j.brainres.2005.11.058
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated ratsPsychopharmacology, 2003
- Neural correlates of the motivational and somatic components of naloxone‐precipitated morphine withdrawalEuropean Journal of Neuroscience, 2002
- Opiate Withdrawal-Induced Fos Immunoreactivity in the Rat Extended Amygdala Parallels the Development of Conditioned Place AversionNeuropsychopharmacology, 2001
- Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonistsEuropean Journal of Pharmacology, 2000
- The pharmacology and mechanism of action of riluzoleNeurology, 1996
- Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis studyBrain Research, 1994
- Neurotransmission in the rat amygdala related to fear and anxietyTrends in Neurosciences, 1994
- Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent miceEuropean Neuropsychopharmacology, 1993
- The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawalLife Sciences, 1992
- Acute opioid physical dependence in humans: Effect of naloxone at 6 and 24 hours postmorphinePharmacology Biochemistry and Behavior, 1990